Objectives

After participating in this educational activity, attendees should be able to:

1|Recognize different Belatacept dosing strategies that are patient specific
2|Summarize the common side effects and patient demographics to give Belatacept
3|Explain emerging indications and titration schedules that will help reduce negative side effects to patient and kidney allograft

 

Presenter(s): 
Erin Naglack, PharmD, BCPS
Clinical Pharmacy Specialist, Renal Transplant
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Erin Naglack, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
06/23/2025 - 2:00pm to 3:00pm EDT
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.